Kevin Joseph Fitzgerald's Net Worth

$7.58 Million

Estimate Recalculated Sep 11, 2024 04:39PM EST

Who is Kevin Joseph Fitzgerald?

Kevin Joseph Fitzgerald has an estimated net worth of $7.58 Million. This is based on reported shares across multiple companies, which include Ovid Therapeutics Inc., and ALNYLAM PHARMACEUTICALS, INC..

SEC CIK

Kevin Joseph Fitzgerald's CIK is 0001886431

Past Insider Trading and Trends

2024 was Kevin Joseph Fitzgerald's most active year for acquiring shares with 4 total transactions. Kevin Joseph Fitzgerald's most active month to acquire stocks was the month of January. 2024 was Kevin Joseph Fitzgerald's most active year for disposing of shares, totalling 20 transactions. Kevin Joseph Fitzgerald's most active month to dispose stocks was the month of May. 2024 saw Kevin Joseph Fitzgerald paying a total of $1,846,429.24 for 53,223 shares, this is the most they've acquired in one year. In 2024 Kevin Joseph Fitzgerald cashed out on 43,948 shares for a total of $6,245,246.35, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ovid Therapeutics Inc. (OVID) Snapshot price: $1.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
Oct 6
Form 3
—
0
—
—
0
No matching records found

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $246.78

CSO & EVP, Head Research

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.17%
-1.30K
$180.04
-$4,122,086.36
12.88K
Scheduled
Aug 12
Form 4
+10.09%
1.3K
$230.99
-$276,730.75
14.18K
Jun 24 - Jun 25
Form 3
—
0
—
—
0
No matching records found